Biotech entity
pharma is the sole category represented across all 2 tracked stories. AbbVie is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Across a 152-day span, the pace is roughly 0.1 stories per week. Each story carries 2 original sources on average, compared with 3.9 for the broader beat in this window.
Last mentioned: Jul 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. AbbVie is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Across a 152-day span, the pace is roughly 0.1 stories per week. Each story carries 2 original sources on average, compared with 3.9 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Skyrizi appears in 2 tracked Biotech stories published from February 27, 2026 through July 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 514 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Skyrizi. Shared-story counts are live from our verified record — not editorial picks.
AbbVie's second-quarter results, expected to show $3.61 EPS, hinge on the continued clinical and commercial success of Rinvoq and Skyrizi. The Apogee deal underscores a deepening immunology pipeline as Humira fades into the rearview.
Source: The Motley Fool · Thomas Niel (us)
RBC Capital has launched coverage of pharmaceutical giant AbbVie with an Outperform rating, signaling confidence in the company's growth trajectory. The initiation suggests that market concerns regarding biosimilar competition for Humira are overstated as newer immunology assets gain significant market share.
Source: finance.yahoo.com · insidermonkey.com
Skyrizi is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
